Randall Michael Giuffre, Director at DiaMedica Therapeutics Inc. (DMAC), bought 94,158 shares at $1.43 ($134K) on 2022-12-09, disclosed to the SEC on 2022-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 20,000 | $28K | 20.9% |
| 2 | $1.43 | 37,079 | $53K | 39.6% |
| 3 | $1.43 | 37,079 | $53K | 39.6% |
| Total | $1.42 avg | 94,158 | $134K | 100% |
| Filing → |
| DMAC | BUY | 2022-12-05 | $975 | — | Filing → |
| DMAC | BUY | 2022-12-01 | $136K | — | Filing → |
| DMAC | BUY | 2020-11-23 | $64K | — | Filing → |